Topical serum for facial aging in people taking GLP-1 medications
Part of Genetic & congenital, Skin clinical trials.
This study tests a topical serum to improve visible signs of facial aging in people who are currently taking a GLP-1 medication. If you qualify, you'll use the serum for the study period and see if it helps with fine lines, sagging, and skin texture.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults aged 25 to 50
- Mild to moderate signs of facial aging (fine lines, sagging, dull texture)
- Currently taking a stable dose of a GLP-1 medication like Ozempic, Rybelsus, or Wegovy for at least 6 months
- No cosmetic procedures on the face (like fillers, laser, or surgery) in the past year
- Willing to sign consent and complete the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a skin serum to improve facial aging signs like fine lines and dullness. It is for post-menopausal women aged 45-65 who are taking a GLP-1 medication (e.g., Ozempic, Wegovy).
This study tests a treatment called poly-L-lactic acid to improve loose skin on the abdomen. It includes women who have been on a stable dose of GLP-1 medication for at least 6 months, as well as a small group who have never taken these drugs.
This study tests a new injectable collagen product to improve the look of facial wrinkles. It aims to see if the treatment is safe and works well for people aged 35 to 65.
This study tests whether a hyaluronic acid filler (a common wrinkle-smoothing treatment) can improve skin quality in women who are taking GLP-1 medications for weight or diabetes. It aims to see if the filler can help with common skin changes like loss of firmness and wrinkles.
This early-phase trial tests whether injections of a substance called secretome can improve facial aging by reducing wrinkles and improving skin elasticity and texture. Participants receive multiple injections over several visits and must be willing to follow a strict skincare routine and avoid other cosmetic procedures during the study.
This study tests an oral supplement to see if it improves signs of facial skin aging in healthy adults. Participants take the supplement daily for 8 weeks and undergo two small skin biopsies on the upper arms to measure changes.
Hear when a new Laxity; Skin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.